J&J Pharma Presents a Robust Pipeline and Outlines A New R&D Structure
This article was originally published in The Pink Sheet Daily
Executive Summary
In a wide-ranging presentation to Wall Street, the company highlights key new products in development and an R&D strategy built around five therapeutic areas.
You may also be interested in...
J&J Takes Leaner, But Stronger Business Approach With Management Consolidation
The health care giant is eliminating some management positions with more organizational announcements expected in coming weeks.
J&J Takes Leaner, But Stronger Business Approach With Management Consolidation
The health care giant is eliminating some management positions with more organizational announcements expected in coming weeks.
Sanofi-Aventis' New R&D Model Aims To Build A Network For Innovation
Anticipated reorganization seems to mimic previous actions by Big Pharma, with an emphasis on external collaboration and a move to smaller, independent groups..